HilleVax logo — HilleVax is a biopharmaceutical company focused on the devel...

HilleVax

HilleVax is a biopharmaceutical company focused on the development and commercialization of novel vaccines.

Founded 2021 United States Boston, United States 76 employees Post-IPO Equity Total: $235.00M Biopharma, Biotechnology +2

General Information

Company Name HilleVax
Founded Year 2021
Location United States Boston, United States
Employees 76
Industries Biopharma, Biotechnology, Health Care +1
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with HilleVax. To contact HilleVax, visit hillevax.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does HilleVax compare?

A PDF of HilleVax and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting HilleVax soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About HilleVax

HilleVax is a biopharmaceutical company founded in 2021 with a focus on the development and commercialization of novel vaccines. The company's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate aimed at preventing moderate-to-severe acute gastroenteritis caused by norovirus infection. HilleVax, based in the United States, recently secured a significant $100.00M Post-IPO Equity investment on 19 September 2023. This infusion of capital reflects a robust interest in the company's innovative approach to vaccine development and marks a significant milestone in its growth trajectory. The continued support from investors underscores the potential of HilleVax in shaping the future of biopharma, biotechnology, health care, and the pharmaceutical industry.

Business keywords: Biopharmaceutical, Vaccine development, Novel vaccines, Virus-like particle (VLP) vaccine, Gastroenteritis prevention, Norovirus, Biotech startup, Healthcare innovation, Biopharmaceutical industry, Clinical development, Commercialization, Medical research, Bioengineering, Bioinnovation, Health technology

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity $100.00M -
19 Sep 2023
Venture Round $135.00M 10
Lightspeed Venture Partners, Greenspring Associates +8
08 Sep 2021

HilleVax Alternatives & Competitors

View All Alternatives
HilleVax vs
AdaptVac
AdaptVac Denmark

AdaptVac aims to accelerate the development of safe and efficacious therapeutic and prophylactic vac...

Grant
10 employees
Biotechnology, Health Care
HilleVax vs
VBI Vaccines Inc.
VBI Vaccines Inc. United States

Driven by Immunology in the Pursuit of Powerful Prevention and Treatment of Disease

Post-IPO Equity
57 employees
Biotechnology, Health Care
HilleVax vs
Valneva
Valneva France

Specialty vaccine company focused on prevention of infectious diseases with major unmet need, such a...

Grant
637 employees
Biotechnology, Health Care

FAQ About HilleVax

HilleVax is a biopharmaceutical company focused on the development and commercialization of novel vaccines.
HilleVax was founded in 2021.
HilleVax is headquartered in Boston, United States.
HilleVax operates in Biopharma, Biotechnology, Health Care and Pharmaceutical. Its work centres on Biopharmaceutical, Vaccine development, Novel vaccines and Virus-like particle (VLP) vaccine.
HilleVax has approximately 76 employees.
HilleVax has completed 2 funding rounds, raising a total of $235.00M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to HilleVax include AdaptVac, VBI Vaccines Inc., Valneva, VaxInnate, Genocea Biosciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
HilleVax and AdaptVac are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for HilleVax, https://bouncewatch.com/company/hillevax, updated 25 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes